Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jennifer Guimbellot

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Jennifer Guimbellot's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jennifer Guimbellot has written about over time.
Molecular Targeted Therapy, 2 publications between 2017 and 2018, average publication date December 2017. Epithelial Cells, 6 publications between 2004 and 2024, average publication date March 2019. Nasal Mucosa, 3 publications between 2017 and 2021, average publication date November 2019. Humans, 31 publications between 2003 and 2024, average publication date December 2019. Cystic Fibrosis Transmembrane Conductance Regulator, 18 publications between 2004 and 2024, average publication date February 2020. Organoids, 3 publications between 2020 and 2021, average publication date March 2021. Mutation, 8 publications between 2017 and 2023, average publication date April 2021. Tacrolimus, 1 publications between 2021 and 2021, average publication date June 2021. Quinolones, 15 publications between 2017 and 2024, average publication date June 2021. Aminophenols, 16 publications between 2017 and 2024, average publication date July 2021. Cystic Fibrosis, 26 publications between 2017 and 2024, average publication date August 2021. Drug Combinations, 3 publications between 2017 and 2024, average publication date January 2022. Benzodioxoles, 8 publications between 2017 and 2024, average publication date January 2022. Pyrrolidines, 4 publications between 2021 and 2023, average publication date March 2022. Indoles, 5 publications between 2021 and 2024, average publication date August 2022. Pyrazoles, 5 publications between 2021 and 2024, average publication date August 2022. Pyridines, 5 publications between 2021 and 2024, average publication date August 2022. Tandem Mass Spectrometry, 3 publications between 2022 and 2024, average publication date November 2023. Neonatal Screening, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Guimbellot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description